{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:36:03Z","timestamp":1793644563419,"version":"4.5.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bmcl.2021.128421","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:42:31Z","timestamp":1635381751000},"page":"128421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19)"],"prefix":"10.1016","volume":"53","author":[{"given":"Jigar","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaumin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Darji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Gite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokul","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Shedage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Kumar Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Joharapurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samadhan","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Bhayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnarup","family":"Ghoshdastidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debdutta","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128421_b0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.tem.2014.07.002","article-title":"Protein and amino acid restriction, aging and disease: from yeast to humans","volume":"25","author":"Mirzaei","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bmcl.2021.128421_b0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cmet.2014.02.009","article-title":"The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in adlibitum-fed mice","volume":"19","author":"Solon-Biet","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmcl.2021.128421_b0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.physiol.66.032102.144149","article-title":"Molecular and integrative physiology of intestinal peptide transport","volume":"66","author":"Daniel","year":"2004","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bmcl.2021.128421_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1152\/physrev.00018.2006","article-title":"Amino acid transport across mammalian intestinal and renal epithelia","volume":"88","author":"Br\u00f6er","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmcl.2021.128421_b0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2472555218755629","article-title":"Amino acid transporters as disease modifiers and drug targets","volume":"23","author":"Br\u00f6er","year":"2018","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.bmcl.2021.128421_b0030","doi-asserted-by":"crossref","first-page":"24467","DOI":"10.1074\/jbc.M400904200","article-title":"Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder","volume":"279","author":"Br\u00f6er","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.128421_b0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1042\/BJ20050083","article-title":"Characterization of Mouse Amino Acid Transporter B0AT1 (slc6a19)","volume":"389","author":"Bohmer","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2021.128421_b0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/chan.5.5.16470","article-title":"Collectrin and ACE2 in renal and intestinal amino acid transport","volume":"5","author":"Singer","year":"2011","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.bmcl.2021.128421_b0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmet.2015.02.003","article-title":"Mice lacking neutral amino acid transporter B0AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control","volume":"4","author":"Jiang","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.bmcl.2021.128421_b0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bph.13711","article-title":"Identification of novel inhibitors of the amino acid transporter B0AT1 (SLC6A19), a potential target to induce protein restriction and to treat type-2 diabetes","volume":"174","author":"Cheng","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2021.128421_b0055","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmcl.2021.128421_b0060","doi-asserted-by":"crossref","unstructured":"Belanger AM, Przybylska M, Gefteas E, Furgerson M, Geller S, Kloss A et al. Inhibiting neutral amino acid transport for the treatment of phenylketonuria. JCI Insight. 2018; 3 (14):e121762.","DOI":"10.1172\/jci.insight.121762"},{"key":"10.1016\/j.bmcl.2021.128421_b0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bcp.2014.03.014","article-title":"Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling","volume":"89","author":"Pochini","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2021.128421_b0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/2472555218794627","article-title":"Identification and characterization of inhibitors of a neutral amino acid transporter, SLC6A19, using two functional cell-based assays","volume":"24","author":"Danthi","year":"2019","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.bmcl.2021.128421_b0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fphar.2020.00140","article-title":"Novel chemical scaffolds to inhibit the neutral amino acid transporter B0AT1 (SLC6A19), a potential target to treat metabolic diseases","volume":"11","author":"Yadav","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2021.128421_b0080","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00002018-200225090-00003","article-title":"Mechanisms of NSAID-induced hepatotoxicitys Focus on nimesulide","volume":"25","author":"Boelsterli","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.bmcl.2021.128421_b0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/tx800152r","article-title":"In vitro nimesulide studies toward understanding idiosyncratic hepatotoxicity: diiminoquinone formation and conjugation","volume":"22","author":"Li","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmcl.2021.128421_b0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1218(86)90077-7","article-title":"Mutagenicity of mononitrobenzene derivatives in the Ames test and rec assay","volume":"170","author":"Shimizu","year":"1986","journal-title":"Mutat Res"},{"key":"10.1016\/j.bmcl.2021.128421_b0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/bbrc.1999.0525","article-title":"Oxidative DNA damage by a metabolite of carcinogenic and reproductive toxic nitrobenzene in the presence of NADH and Cu(II)","volume":"257","author":"Ohkuma","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2021.128421_b0100","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1021\/acs.jmedchem.9b00252","article-title":"The trifluoromethyl group as a bioisosteric replacement of the aliphatic nitro group in CB1 receptor positive allosteric modulators","volume":"62","author":"Chih","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128421_b0105","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1021\/jm800669s","article-title":"Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins","volume":"51","author":"Park","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128421_b0110","unstructured":"N-(2-(3,5-difluorophenoxy)-4-((trifluoromethyl)sulfonyl)phenyl)benzenesulfonamide (39): White powder; mp = 113-117\u00b0C; %purity : 98.43% (UPLC); 1H NMR (400 MHz, DMSO-d6): 11.18 (brs, 1H), 7.94-7.86 (m, 4H), 7.69-7.66 (m, 1H), 7.60-7.56 (m, 3H), 7.10-7.04 (m, 1H), 6.59 (dd, J1 = 2.0 Hz, J2= 8.4 Hz, 2H); MS (ESI): m\/z (%) = 491.98 (M-H)+ ; 19F NMR (400 MHz, DMSO-d6) : -78.53, -108.00; 13C NMR and DEPT (400 MHz, DMSO-d6) : 99.9 (CH), 102.7 (CH), 122.2 (CH), 124.6 (C), 127.1 (CH), 127.9 (CH), 128.9 (CH), 129.8 (CH), 129.9 (CH), 134.0 (CH), 138.7 (C), 140.0 (C), 146.6 (C), 158.0 (C), 162.1(C), 164.4 (C); IR (KBr): \u03bd = 3313 \u03bd(N-H), 3066 \u03bd(=CH), 1363 \u03bd(SO2N-H), 1213 \u03bd(C-F), 1072 \u03bd(Ar-O-Ar)."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2100648X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2100648X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:42:25Z","timestamp":1760773345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2100648X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":22,"alternative-id":["S0960894X2100648X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128421","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128421"}}